Literature DB >> 27572090

Plasma heme oxygenase-1 is decreased in peripheral artery disease patients.

Salvatore Santo Signorelli1, Guido Li Volsi2, Valerio Fiore1, Marco Mangiafico1, Ignazio Barbagallo3, Rosalba Parenti2, Manfredi Rizzo4, Giovanni Li Volti2.   

Abstract

Peripheral artery disease (PAD) is a common manifestation of atherosclerosis. A number of emerging risk factors, including oxidative stress biomarkers, free radicals and heat shock proteins, may add to the established risk factors for cardiovascular disease (CVD). The present study assessed surrogate markers of oxidative stress, including total reduced glutathione (GSH), lipid hydroperoxides (LOOH), isoprostanes, heme oxygenase‑1 (HO‑1) and metabolic biomarkers, such as adiponectin and lactate, in PAD patients (n=27). Healthy age‑matched volunteers (n=27) served as controls. GSH and LOOH were evaluated by measuring total thiol groups and iron oxidation, respectively, by spectrophotometric analysis. Adiponectin, isoprostanes and HO‑1 levels were determined using commercially available ELISA kits and lactate level was determined colorimetrically. Results from patients with PAD demonstrated no significant difference in GSH content and LOOH formation when compared with healthy controls (5.1±7.6 vs. 6.9±9.1 nmol/ml and 6.8±14.2 vs. 8.3±14.9 nmol/ml, respectively), however, isoprostanes were demonstrated to be significantly reduced (3.8±4.8 pg/ml vs. 120±91 pg/mll; P<0.001). Furthermore, HO‑1, a protective heat shock protein, was significantly reduced in PAD patients (0.8±0.7 vs. 3.4±1.3 ng/ml; P<0.001). Adiponectin, an antiatherogenic adipokine, was not significantly different between the two groups (1.4±0.2 vs. 1.5±0.5 µg/ml), whereas serum lactate was significantly higher in PAD patients compared with controls (0.11±0.01 vs. 0.1±0.01 mM; P<0.05). Using multivariate analysis, HO‑1, hypertension, smoking and dyslipidemia were indicated to be independently associated with the presence of PAD, while only ankle‑brachial index was an independent predictor of severity of PAD. The oxidative pathway may be partially involved in the onset and progression of PAD and may represent a target to reduce the risk of ischemic events.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27572090     DOI: 10.3892/mmr.2016.5644

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Biomarkers and Genetics in Peripheral Artery Disease.

Authors:  Surovi Hazarika; Brian H Annex
Journal:  Clin Chem       Date:  2016-11-21       Impact factor: 8.327

Review 2.  Pathophysiology of Peripheral Arterial Disease (PAD): A Review on Oxidative Disorders.

Authors:  Salvatore Santo Signorelli; Elisa Marino; Salvatore Scuto; Domenico Di Raimondo
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

3.  Plasma Heme Oxygenase-1 Levels in Patients with Coronary and Peripheral Artery Diseases.

Authors:  Yoshimi Kishimoto; Susumu Ibe; Emi Saita; Kenji Sasaki; Hanako Niki; Kotaro Miura; Yukinori Ikegami; Reiko Ohmori; Kazuo Kondo; Yukihiko Momiyama
Journal:  Dis Markers       Date:  2018-08-07       Impact factor: 3.434

Review 4.  Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers.

Authors:  Salvatore Santo Signorelli; Salvatore Scuto; Elisa Marino; Anastasia Xourafa; Agostino Gaudio
Journal:  Antioxidants (Basel)       Date:  2019-09-02

5.  Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson's Disease.

Authors:  Wenhua Sun; Jinhua Zheng; Jianjun Ma; Zhidong Wang; Xiaoxue Shi; Mingjian Li; Shen Huang; Shiyu Hu; Zhenxiang Zhao; Dongsheng Li
Journal:  Front Aging Neurosci       Date:  2021-02-12       Impact factor: 5.750

Review 6.  The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress.

Authors:  Jiajia Wu; Siyu Li; Cheng Li; Liying Cui; Jiajia Ma; Yang Hui
Journal:  Redox Biol       Date:  2021-10-20       Impact factor: 11.799

7.  The Status of Nitric Oxide and its Backup, Heme Oxygenase 1, in Thromboangiitis Obliterans.

Authors:  Ali Aliee; Farnaz Zahedi Avval; Hossein Taheri; Saeedeh Mehraban Moghadam; Mohammad Soukhtanloo; Daryoush Hamidi Alamdari; Bahare Fazeli
Journal:  Rep Biochem Mol Biol       Date:  2018-04

Review 8.  Clinical Significance of Heme Oxygenase 1 in Tumor Progression.

Authors:  Mariapaola Nitti; Caterina Ivaldo; Nicola Traverso; Anna Lisa Furfaro
Journal:  Antioxidants (Basel)       Date:  2021-05-17

Review 9.  Oxidative stress and antioxidant treatment in patients with peripheral artery disease.

Authors:  Panagiotis Koutakis; Ahmed Ismaeel; Patrick Farmer; Seth Purcell; Robert S Smith; Jack L Eidson; William T Bohannon
Journal:  Physiol Rep       Date:  2018-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.